Matisse Capital - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Matisse Capital ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$42,000
-89.2%
11,315
-91.6%
0.02%
-86.0%
Q4 2017$390,000
-25.7%
135,445
+15.8%
0.18%
-28.8%
Q3 2017$525,000
-1.9%
116,945
+0.3%
0.25%
-8.1%
Q2 2017$535,000
+400.0%
116,630
+358.6%
0.27%
+369.0%
Q1 2017$107,000
+15.1%
25,430
+13.4%
0.06%
+16.0%
Q4 2016$93,000
-4.1%
22,430
+88.0%
0.05%
-3.8%
Q3 2016$97,00011,9300.05%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders